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OBJECTIVE: Human diploid fibroblasts undergo a limited number of cellular divisions in culture and progressively
reach a state of irreversible growth arrest, a process termed cellular aging. The beneficial effects of vitamin E in
aging have been established, but studies to determine the mechanisms of these effects are ongoing. This study
determined the molecular mechanism of c-tocotrienol, a vitamin E homolog, in the prevention of cellular aging in
human diploid fibroblasts using the expression of senescence-associated genes.
METHODS: Primary cultures of young, pre-senescent, and senescent fibroblast cells were incubated with c-
tocotrienol for 24 h. The expression levels of ELN, COL1A1, MMP1, CCND1, RB1, and IL6 genes were determined
using the quantitative real-time polymerase chain reaction. Cell cycle profiles were determined using a FACSCalibur
Flow Cytometer.
RESULTS: The cell cycle was arrested in the G0/G1 phase, and the percentage of cells in S phase decreased with
senescence. CCND1, RB1, MMP1, and IL6 were upregulated in senescent fibroblasts. A similar upregulation was not
observed in young cells. Incubation with c-tocotrienol decreased CCND1 and RB1 expression in senescent fibroblasts,
decreased cell populations in the G0/G1 phase and increased cell populations in the G2/M phase. c-Tocotrienol
treatment also upregulated ELN and COL1A1 and downregulated MMP1 and IL6 expression in young and senescent
fibroblasts.
CONCLUSION: c-Tocotrienol prevented cellular aging in human diploid fibroblasts, which was indicated by the
modulation of the cell cycle profile and senescence-associated gene expression.
KEYWORDS: Vitamin E; Molecular mechanism; Cellular aging; Senescence-associated genes; Human diploid
fibroblasts.
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The free radical theory of aging suggests that the aging
process involves the accumulation of oxidative damage to
cells and tissues, which progressively increases morbidity
and mortality (1). Human aging can be studied in vitro using
normal human diploid fibroblasts (HDFs), which undergo a
limited number of cellular divisions in culture and
progressively reach a state of irreversible growth arrest;
this process is termed replicative senescence (2).
Replicative senescence is characterized by the loss of
responsiveness to mitogen-induced proliferation (3), altered
growth properties, the expression of senescence-associated
b-galactosidase (SA-b-gal) (4), an enlarged and flattened
morphology with a concomitant increase in the nucleus and
nucleoli, an increase in the number of lysosomes and Golgi,
the appearance of vacuoles in the cytoplasm and endoplas-
mic reticulum and an increase in the number of cytoplasmic
microfilaments (5). In addition to these morphological
changes, the number of multinucleated senescent cells
increases (6). The gradual loss of replicative potential
reduces harvest cell and cell saturation densities (7). A
variety of cell cycle regulation genes, including those
involved in immunity and inflammation, the cytoskeleton,
stress responses and metabolism, are altered during cellular
senescence (8). Serial assessments of gene expression have
been used to explore senescence-associated genes to gain
insight into the molecular mechanisms of senescence.
Several senescence-linked genes have been identified and
cloned based on the changes in mRNA expression levels
between young and senescent cells (9). Senescent cells
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135accumulate in human tissues with age, which suggests that
these cells contribute to organismal aging (10).
Natural vitamin E occurs in eight different forms: a-, b-, c-,
and d-tocopherols and a-, b-, c-, and d-tocotrienols.
11 Vitamin
E is the major chain-breaking antioxidant that prevents the
propagation of oxidative stress, especially in biological
membranes (12). a-Tocopherol modulates signal transduc-
tion and gene expression in an antioxidant and non-
antioxidant manner (11). The non-antioxidant properties of
a-tocopherol, including its roles in cellular signaling, gene
expression, the immune response, and apoptosis, are also
important (13,14).
The tocotrienol isomers have gained increasing scientific
interest due to their prominent antioxidant effects and a
non-antioxidant activity profile that differs from tocopher-
ols (12) Tocotrienols are abundant in plant foods, such as
rice bran and palm oil (15). Tocotrienol is more uniformly
distributed in the membrane bilayer, is more efficiently
recycled from its corresponding chromanoxyl radical form,
and exhibits better interaction with lipid radicals com-
pared to tocopherol. Tocotrienol exhibits better antioxidant
activity than tocopherol (16). Therefore, this study deter-
mined the changes in several molecular markers of cellular
aging, cell cycle profile, and senescence-associated gene
expression in c-tocotrienol-treated HDFs to elucidate
the molecular mechanism involved in the prevention of
cellular aging.
METHODS
Cell culture and the induction of senescence
The Universiti Kebangsaan Malaysia Ethical Committee
approved this research (Approval Project Code: FF-104-
2007). Primary HDFs were derived from the foreskins of
three 9- to 12-year-old boys after circumcision. Written
consents were obtained from the parents of all subjects. The
samples were aseptically collected and washed several
times with 75% alcohol and phosphate-buffered saline (PBS)
containing 1% antibiotic–antimycotic (PAA, Austria). The
epidermis was removed, and the pure dermis was cut into
small pieces and transferred to a Falcon tube containing
0.03% collagenase type I solution (Worthington Biochemical
Corporation, USA). The pure dermis was digested in an
incubator shaker at 37˚C for 6-12 h. The cells were rinsed
with PBS and cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) containing 10% fetal bovine serum (FBS)
(PAA, Austria) and 1% antibiotic–antimycotic at 37˚Ci na
5% CO2 humidified incubator. The cultured HDFs were
harvested after 5–6 days using trypsinization and were
culture-expanded in new T25 culture flasks (Nunc,
Denmark) with an expansion degree of 154. Serial passages
were performed when the subcultures reached 80–90%
confluency using trypsinization, and the number of popula-
tion doublings (PDs) was monitored until the HDFs reached
senescence. The cells were used at passage 4 (young cells,
population doubling; PD,12), passage 20 (pre-senescent
cells, 30,PD,40), or passage 30 (senescent cells, PD.55) in
subsequent experiments.
Effects of various concentrations of c-tocotrienol
on cell viability
Cellular viability was assessed using the CellTiter 96*
Aqueous Non-Radioactive Cell Proliferation Assay (MTS,
Promega, USA). The MTS employs 3-(4,5-dimethylthiazol-2-
yl)-5-carboxymethoxyphenyl) 2-(4-sulfophenyl)-2H-tetrazo-
lium (MTS), and the electron coupling agent, phenazine
methosulphate (PMS). MTS is reduced to a soluble
formazan product by the dehydrogenase enzymes in
metabolically active cells. The amount of colored formazan
product is proportional to the number of viable cells. Briefly,
20 mL of MTS solution was added to each well and was
incubated in a humidified incubator at 37˚Ci n5 %C O 2 for 2-
4 h. The quantity of formazan product was determined by
measuring the absorbance at 490 nm in a microtiter plate
reader (VeraMax Molecular Devices, USA). The viability
assay was performed to obtain the optimum dose of c-
tocotrienol (Malaysian Palm Oil Board) for subsequent
experiments. Young and pre-senescent HDFs were incu-
bated with 50 mM c-tocotrienol, and senescent HDFs were
incubated with 70 mM c-tocotrienol for 24 h. Untreated cells
were cultured in DMEM containing 10% FBS (PAA,
Austria). The media for the untreated cells were changed
in parallel to the treated cells. The untreated and treated
cells were harvested on the same day.
Morphology analysis and senescence-associated
(SA) b-galactosidase staining
The cells were divided into six experiment groups: i) young
HDFs; ii) young HDFs treated with c-tocotrienol; iii) pre-
senescent HDFs; iv) pre-senescent HDFs treated with c-
tocotrienol;v)senescentHDFs;andvi)senescentHDFstreated
with c-tocotrienol. SA-b-gal activity, the molecular marker of
HDF cellular aging in vitro, was determined using a senescent
cell staining kit (Sigma, USA) according to the manufacturer’s
instructions. Blue staining was visible after 4 h of incubation
with a b-galactosidase staining solution containing 5-bromo-4-
chloro-3-indolyl-b-D-galactosidase (X-gal) at 37˚C. The per-
centage ofblue cells in 100 observed cells was calculatedunder
a light microscope.
Cell cycle analysis
The six groups of HDFs were subcultured in 10 cm
2 tissue
culture dishes. The cells were prepared after 24 h of
incubation with c-tocotrienol using the CycleTEST
TM
PLUS DNA Reagent Kit (Becton Dickinson, USA) according
to the manufacturer’s instructions. Cell cycle status was
analyzed by flow cytometry using propidium iodide (PI) as
a specific fluorescent dye probe. The PI fluorescence
intensity of 10,000 cells was measured in each sample using
a Becton–Dickinson FACSCalibur Flow Cytometer.
Primer design
The primers for human GAPDH, COL1A1, ELN, MMP1,
IL6, RB1, and CCND1 were designed using Primer 3
software and were blasted with GenBank database se-
quences to obtain high-specificity primers. The efficiency
and specificity of each primer set were confirmed using a
standard curve (Ct value versus serial dilution of total RNA)
and melting profile evaluation. The primer sequences for
quantitative gene expression analysis are shown in Table 1.
Total RNA extraction
Total RNA from HDFs in different groups was extracted
using TRI Reagent (Molecular Research Center, Cincinnati,
OH) according to the manufacturer’s instructions. Polyacryl
Carrier (Molecular Research Center) was added to each
extraction to precipitate the total RNA. The extracted total
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136RNA pellet was washed with 75% ethanol and dried prior to
dissolution in RNase- and DNase-free distilled water. Total
RNA was stored at -80˚C immediately after extraction. A
Nanodrop (Thermo Scientific, USA) was used to determine
the yield and purity of the extracted RNA.
Quantitative real-time RT-PCR
The expression levels of matrix metalloproteinase 1
(MMP1), inflammation mediator (IL6), extracellular matrix
(COL1A1 and ELN), and cell cycle regulatory genes (RB1
and CCND1) were quantitatively analyzed using a one-step
RT-PCR technique. The expression level of each targeted
gene was normalized to that of GAPDH (17). The reaction
was performed using 100 ng of total RNA, a concentration
of 400 nM for each primer and the iScript One-Step RT-PCR
kit with SYBR Green (Bio-Rad, Canada) according to the
manufacturer’s instructions. Reactions were performed in a
Bio-Rad iCycler with the following reaction profile: cDNA
synthesis for 30 min at 50˚C; predenaturation for 2 min at
94˚C; and PCR amplification for 38 cycles of 30 sec at 94˚C,
30 sec at 61˚C. A melt curve analysis determined the
reaction specificity. Agarose gel electrophoresis was per-
formed to confirm the PCR products. The relative expres-
sion values of target genes were calculated using the 2
2DDCt
method of relative quantification (18) and the following
equation:
Relative expression value ~ 2 Ct value of GAPDH  Ct value gene of interest
Statistical Analysis
Each experiment was performed in triplicate using at least
three independent cultures with comparable results. Data
are reported as the means¡SD of at least three experiments.
ANOVA and the Student’s t-test (two-tailed) were used to
compare differences between groups. p,0.05 was consid-
ered statistically significant.
RESULTS
Effect of c-tocotrienol on cells viability
Incubation with increasing concentrations of c-tocotrienol
for 24 h (10, 20, 30, 40, 50, 60, 70, 80, 90, and 100 mM)
significantly increased the viability of young and senescent
HDFs (Figure 1). c-Tocotrienol concentrations of 50 and
70 mM exhibited the greatest percentages of viable cells
in young and senescent HDFs, respectively. Therefore,
subsequent experiments used 50 mM c-tocotrienol in young
and pre-senescent HDFs and 70 mM c-tocotrienol in senes-
cent HDFs. Higher concentrations of c-tocotrienol reduced
the viability of HDFs.
Cellular morphology and SA-b-galactosidase
expression
Morphological changes were observed in aging HDFs.
Young HDFs displayed the normal spindle shape of
fibroblast cells. However, the original fibroblastic shape
was lost with senescence, and HDFs became large and
flattened (Figure 2). No morphological differences were
detected in the c-tocotrienol-treated group compared to the
untreated group in different passages of HDFs.
The positive blue SA-b-galactosidase stain primarily
appeared in HDFs at passage 30, which suggested the
presence of senescent cells (Figure 3A). Quantitative
Table 1 - Primer sequences for quantitative real-time RT-PCR.
Gene Accession number
Sequence (59R39)
Sense and antisense primers Product size, base pairs (bp)
GAPDH NM_002046 F: tcc ctg agc tga acg gga ag
R: gga gga gtg ggt gtc gct gt
217
MMP1 NM_002421 F: gct cct ttg gct tcc cta ga
R: gca tca act ttg tgg cca at
187
IL6 NM_000600 F: tgg ctg aaa aag atg gat gc
R: tgc agg aac tgg atc agg ac
181
CCND1 NM_053056 F: aga cct tcg ttg ccc tct gt
R: cag tcc ggg tca cac ttg at
181
ELN NM000501 F: ggc ctg gag gca aac ctc tt
R: cca cca act cct ggg aca cc
189
RB1 NM_000321 F: cag acc cag aag cca ttg aa
R: ctg ggt gct cag aca gaa gg
115
COL1A1 NM_000088 F: agg gct cca acg aga tcg aga tcc g
R: tac agg aag cag aca ggg cca acg
222
Figure 1 - Dose response of c-tocotrienol in young and senescent
HDFs after incubation for 24 h at 37˚C. Incubation with c-
tocotrienol produced a significant increase in the viability of
HDFs. The percentages of viable cells were highest at c-
tocotrienol concentrations of 50 mM in young HDFs and 70 mM
in senescent HDFs. However, HDF viability decreased with high
concentrations of c-tocotrienol. * Denotes p,0.05 compared to
control. Data are presented as means ¡ SD, n=9.
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137analysis revealed that the percentage of SA-b-gal-positive
cells increased (p,0.05) in senescent cells compared to
young and pre-senescent HDFs. The incubation of senescent
cells with 70 mM c-tocotrienol did not alter the percentage of
SA-b-gal-positive cells (Figure 3B).
Cell cycle progression
The cell populations in the S phase were significantly
lower (p,0.05) in pre-senescent and senescent HDFs
compared to young HDFs. The cell populations in the G0/
G1 phase in pre-senescent and senescent HDFs were
significantly higher (p,0.05) compared to young HDFs
(Figure 4).
c-Tocotrienol significantly decreased (p,0.05) the percen-
tage of senescent HDFs in the G0/G1 phase. In contrast,
c-tocotrienol significantly increased (p,0.05) the percentage
of senescent HDFs in the G2/M phase (Figure 5).
Effect of c-tocotrienol on the expression of
senescence-associated genes
Six pairs of senescence-associated gene primers were
designed. Agarose gel electrophoresis revealed that each
PCR product appeared as a single band (Figure 1S). The
melting curve analysis demonstrated a single and narrow
peak for each PCR product (Figure 2S), which indicated that
the primers and RT-PCR protocols were specific.
Senescent cells exhibited significant increases in MMP1, IL6,
CCND1, and RB1 mRNA expression levels compared to
young HDFs (p,0.05). However, c-tocotrienol produced
significant downregulations of MMP1 mRNA expression in
Figure 2 - Morphological changes in HDFs in culture. Young (A), pre-senescent (B), and senescent (C) HDFs compared to c-tocotrienol-
treated HDFs (D–F). Senescent HDFs lost their original fibroblastic shape and acquiring a flattened morphology (indicated by arrow).
The size of the nucleus and cell increased in treated and untreated groups. Micrographs are shown at 100X magnification.
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138pre-senescent and senescent HDFs compared to untreated
cells (p,0.05) (Figure 6A). c-Tocotrienol produced significant
(p,0.05) upregulations of COL1A1 in young, pre-senescent,
and senescent HDFs (Figure 6B). c-Tocotrienol also signifi-
cantly upregulated ELN mRNAin young and senescent HDFs
(p,0.05) (Figure 6C). c-Tocotrienol significantly downregu-
lated IL6 (Figure 6D), CCND1 (Figure 6E) and RB1 (Figure 6F)
mRNA expression in senescent HDFs (p,0.05).
DISCUSSION
This study evaluated the effects of c-tocotrienol in the
modulation of cellular aging in HDFs. Our results demon-
strated clear changes in cellular morphology, decreased
cellular proliferation, and increased senescence-associated
b-galactosidase activity in senescent HDFs. Cellular and
organism morphological changes are typical features of a
Figure 3 - Senescence-associated b-galactosidase (SA b-gal) staining in young (a), pre-senescent (b), and senescent HDFs (c). Positive blue
stains of SA b-gal appeared in senescent HDFs as indicated by arrows. Micrographs are shown at 100X magnification (A). Quantitative
analysis of positive b-galactosidase-stained cells in HDFs during cellular aging. The percentage of cells positive for SA-b-gal staining was
significantly increased in senescent cells. The incubation of senescent cells with c-tocotrienol (70 mM for 24 h) did not produce significant
changes in the percentage of SA-b-gal-positive cells.
aDenotes p,0.05 compared to untreated young HDFs,
bp,0.05 compared to
untreated pre-senescent HDFs. Data are presented as means ¡ SD, n=6.
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139senescent phenotype (19). The enlargement and flattening of
senescent HDFs is accompanied by changes in nuclear
structure, gene expression, protein processing and metabo-
lism (4) and an increase in the activity of senescence-
associated b-galactosidase at pH 6 (6,20). The flattened cell
appearance may be due to the significant upregulation of
matrix metalloproteinase 1 (MMP1) mRNA and an increase
in extracellular matrix degradation in aged cells. Previous
study reported the overexpression of matrix metalloprotei-
nases (MMPs) gene in senescent cells which results in the loss
of proteins that maintain the ultrastructural shape. The
relative overproduction of collagenase in aging cells suggests
a matrix-degrading phenotype of senescent cells (21).
Our results demonstrated that c-tocotrienol downregu-
lated MMP1 mRNA expression in pre-senescent and
senescent HDFs. This result suggested that c-tocotrienol
reduced the aging process via the inhibition of extracellular
matrix degradation. Senescent HDFs exhibit lower expres-
sion levels of several extracellular matrix components, such
as collagen I-1a, collagen III-1a and elastin, and increased
expression levels of collagenase and stromelysin, which
degrade the extracellular matrix. These data are consistent
with the upregulation of MMP1 mRNA in senescent HDFs
in our study. The increased expression of COL1A1 mRNA
in young, pre-senescent, and senescent HDFs and the
increased ELN mRNA expression levels in young and
senescent HDFs demonstrated an important role for c-
tocotrienol in the maintenance of extracellular matrix
architecture during various stages of cellular aging.
Senescent cells disrupt normal tissue structures and
functions in complex cell culture models. For example,
senescent stromal fibroblasts derange the normal organiza-
tion and specialized function of mammary epithelial cells
(22,23). The effects of senescent cells on mammary epithelial
cells were produced by the secretion of MMPs, which is
similar to the effects of senescent cells on fibrosis resolution.
Osteoblasts undergo age-related cellular senescence because
of the increase in oxidative stress in aged bones (24).
Senescent osteoblasts alter the bone microenvironment,
which contributes to the development of age-related
osteoporosis (24,25). Therefore, the c-tocotrienol-induced
downregulation of MMP1 and upregulation of COL1A1
and ELN in our study suggest a medicinal role in the
maintenance of normal tissue structures and functions.
Our data demonstrated an increase in cell populations in
the G0/G1 phase and a decrease in S-phase cells during HDF
aging. Although senescent cells display some characteristics
of a late G1 arrest, these cells are actually arrested in a
distinct state within a specific pathway (26). Senescent HDFs
contain higher levels of oxidative DNA lesions compared to
early passage cells, which suggests that oxidative damage
triggers the onset of cell cycle checkpoints in senescent cells
(27). The presence of damaged DNA activates checkpoint
pathways, which inhibit the progression of cells through the
G1 and G2 phases and induce a delay in cell cycle
progression through the S phase. These checkpoints allow
sufficient time to repair the damaged DNA prior to the
resumption of cell cycle progression (28). Therefore, an
increase in the number of cells in the G2/M phase in
c-tocotrienol treated senescent HDFs suggested that
c-tocotrienol decreased the amount of damaged DNA in
aged cells and modulated the expression of cell cycle
regulatory genes. Our previous results showed that a
tocotrienol-rich fraction protected against DNA damage in
senescent HDFs via the prevention of oxidative stress-
induced DNA damage or the enhancement of the DNA
repair mechanism (29).
The reduction in S-phase cells with senescence suggests a
slowing of cellular proliferation when entering replicative
senescence. The increase in the expression of the cell cycle
regulatory genes RB1 and CCND1 that was observed in this
study may explain this reduction. RB1 mRNA is intimately
involved in cellular aging in senescent HDFs. Senescent cells
do not phosphorylate the Rb protein, which leads to
inactivation of Rb and cellular progression into the S phase
(30). The impairment of this mechanism in senescent cells
increases the expression of Rb and retains Rb in a
hypophosphorylated inhibitory form. Our results demon-
strated that c-tocotrienol decreased the expression of RB1
mRNA in senescent HDFs.
Alterations in the expression or activity of gene products
that are normally active in the G0/G1 to S progression likely
play a pivotal role in cellular senescence (29). Our findings
demonstrated an upregulation of CCND1 RNA in senescent
HDFs. Senescent cells were arrested at G0/G1 phase where
the expression of cyclin D1 was at the highest. Our finding
was similar to a previous report which suggested that
senescent cells might lack a feedback control mechanism
Figure 4 - Quantitative analysis of cell cycle progression in HDFs.
aDenotes p,0.05 compared to young HDFs (G0/G1 phase),
bp,0.05
compared to young HDFs (S phase), and
cp,0.05 compared to pre-senescent HDFs (S phase). Data are presented as means ¡ SD, n=6.
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140that negatively regulates cyclin D1 expression. However, c-
tocotrienol downregulated CCND1 mRNA in senescent
HDFs, reduced the cellular population in the G0/G1 phase
and increased the population in the G2/M phase. These
results suggest that c-tocotrienol inhibited cell growth arrest
and enhanced cellular proliferation in senescent HDFs. Our
Figure 5 - Cell cycle analysis with c-tocotrienol treatment. *Denotes p,0.05 compared to control. Data are presented as means ¡ SD,
n=6.
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141recent findings demonstrated that a tocotrienol-rich fraction
(TRF) prevented cellular aging in HDFs by reversing the cell
cycle arrest that is associated with cellular senescence and
promoted cell cycle progression at different stages of
cellular aging (29).
Stress-like conditions and inflammation are chronic
during aging (31). Cytokines are important proinflamma-
tory mediators, and aged individuals exhibit increased
serum levels of proinflammatory cytokines, such as IL-1, IL-
6, TNF-a, and IL-8, compared to young individuals (32). Our
data demonstrated an upregulation of IL6 in senescent
HDFs compared to the young control group. However, c-
tocotrienol downregulated IL6 mRNA in senescent HDFs.
In summary, c-tocotrienol decreased the percentage of
cells in the G0/G1 phase and increased the percentage of
cells in the G2/M phase. c-Tocotrienol also modulated
senescence-associated gene expression; the expression levels
of MMP1, IL6, CCND1, and RB1 were downregulated, but
COL1A1 and ELN expression levels were upregulated.
These results support the role of c-tocotrienol in the
prevention of cellular aging in HDFs.
c-Tocotrienol prevented the cellular aging of human
diploid fibroblasts via modulation of the cell cycle profile
and senescence-associated gene expression.
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